Page 28 - NON-INVASIVE TESTS FOR EVALUATION OF LIVER DISEASE SEVERITY AND PROGNOSIS
P. 28
[287] Bureau C, Metivier S, Peron JM, Selves J, Robic MA, Gourraud PA, et al. JOURNAL OF HEPATOLOGY
Transient elastography accurately predicts presence of significant portal
hypertension in patients with chronic liver disease. Aliment Pharmacol [308] Sebastiani G, Tempesta D, Fattovich G, Castera L, Halfon P, Bourliere M,
Ther 2008;27:1261–1268. et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum
non-invasive markers: results of a multicenter, large-scale study. J Hepatol
[288] Lemoine M, Katsahian S, Ziol M, Nahon P, Ganne-Carrie N, Kazemi F, et al. 2010;53:630–638.
Liver stiffness measurement as a predictive tool of clinically significant
portal hypertension in patients with compensated hepatitis C virus or [309] Thabut D, Trabut JB, Massard J, Rudler M, Muntenau M, Messous D, et al.
alcohol-related cirrhosis. Aliment Pharmacol Ther 2008;28:1102–1110. Non-invasive diagnosis of large oesophageal varices with FibroTest in
patients with cirrhosis: a preliminary retrospective study. Liver Int
[289] Shi KQ, Fan YC, Pan ZZ, Lin XF, Liu WY, Chen YP, et al. Transient 2006;26:271–278.
elastography: a meta-analysis of diagnostic accuracy in evaluation of portal
hypertension in chronic liver disease. Liver Int 2013;33:62–71. [310] Feier D, Lupsor Platon M, Stefanescu H, Badea R. Transient elastography for
the detection of hepatocellular carcinoma in viral C liver cirrhosis. Is there
[290] Llop E, Berzigotti A, Reig M, Erice E, Reverter E, Seijo S, et al. Assessment of something else than increased liver stiffness? J Gastrointestin Liver Dis
portal hypertension by transient elastography in patients with compen- 2013;22:283–289.
sated cirrhosis and potentially resectable liver tumors. J Hepatol
2012;56:103–108. [311] Kuo YH, Lu SN, Hung CH, Kee KM, Chen CH, Hu TH, et al. Liver stiffness
measurement in the risk assessment of hepatocellular carcinoma for
[291] Reiberger T, Ferlitsch A, Payer BA, Pinter M, Homoncik M, Peck- patients with chronic hepatitis. Hepatol Int 2010;4:700–706.
Radosavljevic M. Non-selective beta-blockers improve the correlation of
liver stiffness and portal pressure in advanced cirrhosis. J Gastroenterol [312] Masuzaki R, Tateishi R, Yoshida H, Yoshida H, Sato S, Kato N, et al. Risk
2012;47:561–568. assessment of hepatocellular carcinoma in chronic hepatitis C patients by
transient elastography. J Clin Gastroenterol 2008;42:839–843.
[292] Carrion JA, Torres F, Crespo G, Miquel R, Garcia-Valdecasas JC, Navasa M,
et al. Liver stiffness identifies two different patterns of fibrosis progression [313] Nahon P, Kettaneh A, Lemoine M, Seror O, Barget N, Trinchet JC, et al. Liver
in patients with hepatitis C virus recurrence after liver transplantation. stiffness measurement in patients with cirrhosis and hepatocellular carcino-
Hepatology 2010;51:23–34. ma: a case-control study. Eur J Gastroenterol Hepatol 2009;21: 214–219.
[293] Crespo G, Lens S, Gambato M, Carrion JA, Marino Z, Londono MC, et al. Liver [314] Akima T, Tamano M, Hiraishi H. Liver stiffness measured by transient
stiffness 1 year after transplantation predicts clinical outcomes in patients elastography is a predictor of hepatocellular carcinoma development in
with recurrent hepatitis C. Am J Transplant 2014;14:375–383. viral hepatitis. Hepatol Res 2011;41:965–970.
[294] Kazemi F, Kettaneh A, N’Kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, [315] Chon YE, Jung ES, Park JY, Kim do Y, Ahn SH, Han KH, et al. The accuracy of
et al. Liver stiffness measurement selects patients with cirrhosis at risk of noninvasive methods in predicting the development of hepatocellular
bearing large oesophageal varices. J Hepatol 2006;45:230–235. carcinoma and hepatic decompensation in patients with chronic hepatitis
B. J Clin Gastroenterol 2012;46:518–525.
[295] Nguyen-Khac E, Saint-Leger P, Tramier B, Coevoet H, Capron D, Dupas JL.
Noninvasive diagnosis of large esophageal varices by fibroscan: strong [316] Jung KS, Kim SU, Ahn SH, Park YN, Kim do Y, Park JY, et al. Risk assessment
influence of the cirrhosis etiology. Alcohol Clin Exp Res 2010;34: of hepatitis B virus-related hepatocellular carcinoma development using
1146–1153. liver stiffness measurement (FibroScan). Hepatology 2011;53:885–894.
[296] Pritchett S, Cardenas A, Manning D, Curry M, Afdhal NH. The optimal cut- [317] Masuzaki R, Tateishi R, Yoshida H, Goto E, Sato T, Ohki T, et al. Prospective
off for predicting large oesophageal varices using transient elastography is risk assessment for hepatocellular carcinoma development in patients with
disease specific. J Viral Hepat 2011;18:e75–e80. chronic hepatitis C by transient elastography. Hepatology 2009;49:
1954–1961.
[297] Castera L, Pinzani M, Bosch J. Non invasive evaluation of portal hyperten-
sion using transient elastography. J Hepatol 2012;56:696–703. [318] Narita Y, Genda T, Tsuzura H, Sato S, Kanemitsu Y, Ishikawa S, et al.
Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C
[298] Stefanescu H, Grigorescu M, Lupsor M, Procopet B, Maniu A, Badea R. patients on interferon-based anti-viral therapy. J Gastroenterol Hepatol
Spleen stiffness measurement using Fibroscan for the noninvasive assess- 2014;29:137–143.
ment of esophageal varices in liver cirrhosis patients. J Gastroenterol
Hepatol 2011;26:164–170. [319] Wang HM, Hung CH, Lu SN, Chen CH, Lee CM, Hu TH, et al. Liver stiffness
measurement as an alternative to fibrotic stage in risk assessment of
[299] Takuma Y, Nouso K, Morimoto Y, Tomokuni J, Sahara A, Toshikuni N, et al. hepatocellular carcinoma incidence for chronic hepatitis C patients. Liver
Measurement of spleen stiffness by acoustic radiation force impulse Int 2013;33:756–761.
imaging identifies cirrhotic patients with esophageal varices.
Gastroenterology 2012;144:e102. [320] Kim do Y, Song KJ, Kim SU, Yoo EJ, Park JY, Ahn SH, et al. Transient
elastography-based risk estimation of hepatitis B virus-related occurrence
[300] Colecchia A, Montrone L, Scaioli E, Bacchi-Reggiani ML, Colli A, Casazza G, of hepatocellular carcinoma: development and validation of a predictive
et al. Measurement of spleen stiffness to evaluate portal hypertension and model. Onco Targets Ther 2013;6:1463–1469.
the presence of esophageal varices in patients with HCV-related cirrhosis.
Gastroenterology 2012;143:646–654. [321] Kim SU, Lee JH, Kim do Y, Ahn SH, Jung KS, Choi EH, et al. Prediction of liver-
related events using fibroscan in chronic hepatitis B patients showing
[301] Sharma P, Kirnake V, Tyagi P, Bansal N, Singla V, Kumar A, et al. Spleen advanced liver fibrosis. PLoS One 2012;7:e36676.
stiffness in patients with cirrhosis in predicting esophageal varices. Am J
Gastroenterol 2013;108:1101–1107. [322] Robic MA, Procopet B, Metivier S, Peron JM, Selves J, Vinel JP, et al. Liver
stiffness accurately predicts portal hypertension related complications in
[302] Calvaruso V, Bronte F, Conte E, Simone F, Craxi A, Di Marco V. Modified patients with chronic liver disease: A prospective study. J Hepatol 2011;55:
spleen stiffness measurement by transient elastography is associated with 1017–1024.
presence of large oesophageal varices in patients with compensated
hepatitis C virus cirrhosis. J Viral Hepat 2013;20:867–874. [323] Poynard T, Vergniol J, Ngo Y, Foucher J, Munteanu M, Merrouche W, et al.
Staging chronic hepatitis C in seven categories using fibrosis biomarker
[303] Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, et al. Platelet (FibroTest) and transient elastography (FibroScan(R)). J Hepatol 2014;60:
count/spleen diameter ratio: proposal and validation of a non-invasive 706–714.
parameter to predict the presence of oesophageal varices in patients with
liver cirrhosis. Gut 2003;52:1200–1205. [324] Wong GL, Chan HL, Wong CK, Leung C, Chan CY, Ho PP, et al. Liver stiffness-
based optimization of hepatocellular carcinoma risk score in patients with
[304] Giannini EG, Zaman A, Kreil A, Floreani A, Dulbecco P, Testa E, et al. Platelet chronic hepatitis B. J Hepatol 2014;60:339–345.
count/spleen diameter ratio for the noninvasive diagnosis of esophageal
varices: results of a multicenter, prospective, validation study. Am J [325] Wong VW, Chan SL, Mo F, Chan TC, Loong HH, Wong GL, et al. Clinical
Gastroenterol 2006;101:2511–2519. scoring system to predict hepatocellular carcinoma in chronic hepatitis B
carriers. J Clin Oncol 2010;28:1660–1665.
[305] Kim BK, Han KH, Park JY, Ahn SH, Kim JK, Paik YH, et al. A liver stiffness
measurement-based, noninvasive prediction model for high-risk esopha- [326] Merchante N, Rivero-Juarez A, Tellez F, Merino D, Jose Rios-Villegas M,
geal varices in B-viral liver cirrhosis. Am J Gastroenterol 2010;105: Marquez-Solero M, et al. Liver stiffness predicts clinical outcome in human
1382–1390. immunodeficiency virus/hepatitis C virus-coinfected patients with com-
pensated liver cirrhosis. Hepatology 2012;56:228–238.
[306] Park SH, Park TE, Kim YM, Kim SJ, Baik GH, Kim JB, et al. Non-invasive
model predicting clinically-significant portal hypertension in patients with [327] Macias J, Camacho A, Von Wichmann MA, Lopez-Cortes LF, Ortega E, Tural
advanced fibrosis. J Gastroenterol Hepatol 2009;24:1289–1293. C, et al. Liver stiffness measurement versus liver biopsy to predict survival
and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected
[307] Thabut D, Imbert-Bismut F, Cazals-Hatem D, Messous D, Muntenau M, patients. Aids 2013;27:2541–2549.
Valla DC, et al. Relationship between the Fibrotest and portal hypertension
in patients with liver disease. Aliment Pharmacol Ther 2007;26:359–368. [328] Pang JX, Zimmer S, Niu S, Crotty P, Tracey J, Pradhan F, et al. Liver stiffness
by transient elastography predicts liver-related complications and mortal-
ity in patients with chronic liver disease. PLoS One 2014;9:e95776.
Journal of Hepatology 2015 vol. xxx j xxx–xxx 27
Please cite this article in press as: EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J
Hepatol (2015), http://dx.doi.org/10.1016/j.jhep.2015.04.006
Transient elastography accurately predicts presence of significant portal
hypertension in patients with chronic liver disease. Aliment Pharmacol [308] Sebastiani G, Tempesta D, Fattovich G, Castera L, Halfon P, Bourliere M,
Ther 2008;27:1261–1268. et al. Prediction of oesophageal varices in hepatic cirrhosis by simple serum
non-invasive markers: results of a multicenter, large-scale study. J Hepatol
[288] Lemoine M, Katsahian S, Ziol M, Nahon P, Ganne-Carrie N, Kazemi F, et al. 2010;53:630–638.
Liver stiffness measurement as a predictive tool of clinically significant
portal hypertension in patients with compensated hepatitis C virus or [309] Thabut D, Trabut JB, Massard J, Rudler M, Muntenau M, Messous D, et al.
alcohol-related cirrhosis. Aliment Pharmacol Ther 2008;28:1102–1110. Non-invasive diagnosis of large oesophageal varices with FibroTest in
patients with cirrhosis: a preliminary retrospective study. Liver Int
[289] Shi KQ, Fan YC, Pan ZZ, Lin XF, Liu WY, Chen YP, et al. Transient 2006;26:271–278.
elastography: a meta-analysis of diagnostic accuracy in evaluation of portal
hypertension in chronic liver disease. Liver Int 2013;33:62–71. [310] Feier D, Lupsor Platon M, Stefanescu H, Badea R. Transient elastography for
the detection of hepatocellular carcinoma in viral C liver cirrhosis. Is there
[290] Llop E, Berzigotti A, Reig M, Erice E, Reverter E, Seijo S, et al. Assessment of something else than increased liver stiffness? J Gastrointestin Liver Dis
portal hypertension by transient elastography in patients with compen- 2013;22:283–289.
sated cirrhosis and potentially resectable liver tumors. J Hepatol
2012;56:103–108. [311] Kuo YH, Lu SN, Hung CH, Kee KM, Chen CH, Hu TH, et al. Liver stiffness
measurement in the risk assessment of hepatocellular carcinoma for
[291] Reiberger T, Ferlitsch A, Payer BA, Pinter M, Homoncik M, Peck- patients with chronic hepatitis. Hepatol Int 2010;4:700–706.
Radosavljevic M. Non-selective beta-blockers improve the correlation of
liver stiffness and portal pressure in advanced cirrhosis. J Gastroenterol [312] Masuzaki R, Tateishi R, Yoshida H, Yoshida H, Sato S, Kato N, et al. Risk
2012;47:561–568. assessment of hepatocellular carcinoma in chronic hepatitis C patients by
transient elastography. J Clin Gastroenterol 2008;42:839–843.
[292] Carrion JA, Torres F, Crespo G, Miquel R, Garcia-Valdecasas JC, Navasa M,
et al. Liver stiffness identifies two different patterns of fibrosis progression [313] Nahon P, Kettaneh A, Lemoine M, Seror O, Barget N, Trinchet JC, et al. Liver
in patients with hepatitis C virus recurrence after liver transplantation. stiffness measurement in patients with cirrhosis and hepatocellular carcino-
Hepatology 2010;51:23–34. ma: a case-control study. Eur J Gastroenterol Hepatol 2009;21: 214–219.
[293] Crespo G, Lens S, Gambato M, Carrion JA, Marino Z, Londono MC, et al. Liver [314] Akima T, Tamano M, Hiraishi H. Liver stiffness measured by transient
stiffness 1 year after transplantation predicts clinical outcomes in patients elastography is a predictor of hepatocellular carcinoma development in
with recurrent hepatitis C. Am J Transplant 2014;14:375–383. viral hepatitis. Hepatol Res 2011;41:965–970.
[294] Kazemi F, Kettaneh A, N’Kontchou G, Pinto E, Ganne-Carrie N, Trinchet JC, [315] Chon YE, Jung ES, Park JY, Kim do Y, Ahn SH, Han KH, et al. The accuracy of
et al. Liver stiffness measurement selects patients with cirrhosis at risk of noninvasive methods in predicting the development of hepatocellular
bearing large oesophageal varices. J Hepatol 2006;45:230–235. carcinoma and hepatic decompensation in patients with chronic hepatitis
B. J Clin Gastroenterol 2012;46:518–525.
[295] Nguyen-Khac E, Saint-Leger P, Tramier B, Coevoet H, Capron D, Dupas JL.
Noninvasive diagnosis of large esophageal varices by fibroscan: strong [316] Jung KS, Kim SU, Ahn SH, Park YN, Kim do Y, Park JY, et al. Risk assessment
influence of the cirrhosis etiology. Alcohol Clin Exp Res 2010;34: of hepatitis B virus-related hepatocellular carcinoma development using
1146–1153. liver stiffness measurement (FibroScan). Hepatology 2011;53:885–894.
[296] Pritchett S, Cardenas A, Manning D, Curry M, Afdhal NH. The optimal cut- [317] Masuzaki R, Tateishi R, Yoshida H, Goto E, Sato T, Ohki T, et al. Prospective
off for predicting large oesophageal varices using transient elastography is risk assessment for hepatocellular carcinoma development in patients with
disease specific. J Viral Hepat 2011;18:e75–e80. chronic hepatitis C by transient elastography. Hepatology 2009;49:
1954–1961.
[297] Castera L, Pinzani M, Bosch J. Non invasive evaluation of portal hyperten-
sion using transient elastography. J Hepatol 2012;56:696–703. [318] Narita Y, Genda T, Tsuzura H, Sato S, Kanemitsu Y, Ishikawa S, et al.
Prediction of liver stiffness hepatocellular carcinoma in chronic hepatitis C
[298] Stefanescu H, Grigorescu M, Lupsor M, Procopet B, Maniu A, Badea R. patients on interferon-based anti-viral therapy. J Gastroenterol Hepatol
Spleen stiffness measurement using Fibroscan for the noninvasive assess- 2014;29:137–143.
ment of esophageal varices in liver cirrhosis patients. J Gastroenterol
Hepatol 2011;26:164–170. [319] Wang HM, Hung CH, Lu SN, Chen CH, Lee CM, Hu TH, et al. Liver stiffness
measurement as an alternative to fibrotic stage in risk assessment of
[299] Takuma Y, Nouso K, Morimoto Y, Tomokuni J, Sahara A, Toshikuni N, et al. hepatocellular carcinoma incidence for chronic hepatitis C patients. Liver
Measurement of spleen stiffness by acoustic radiation force impulse Int 2013;33:756–761.
imaging identifies cirrhotic patients with esophageal varices.
Gastroenterology 2012;144:e102. [320] Kim do Y, Song KJ, Kim SU, Yoo EJ, Park JY, Ahn SH, et al. Transient
elastography-based risk estimation of hepatitis B virus-related occurrence
[300] Colecchia A, Montrone L, Scaioli E, Bacchi-Reggiani ML, Colli A, Casazza G, of hepatocellular carcinoma: development and validation of a predictive
et al. Measurement of spleen stiffness to evaluate portal hypertension and model. Onco Targets Ther 2013;6:1463–1469.
the presence of esophageal varices in patients with HCV-related cirrhosis.
Gastroenterology 2012;143:646–654. [321] Kim SU, Lee JH, Kim do Y, Ahn SH, Jung KS, Choi EH, et al. Prediction of liver-
related events using fibroscan in chronic hepatitis B patients showing
[301] Sharma P, Kirnake V, Tyagi P, Bansal N, Singla V, Kumar A, et al. Spleen advanced liver fibrosis. PLoS One 2012;7:e36676.
stiffness in patients with cirrhosis in predicting esophageal varices. Am J
Gastroenterol 2013;108:1101–1107. [322] Robic MA, Procopet B, Metivier S, Peron JM, Selves J, Vinel JP, et al. Liver
stiffness accurately predicts portal hypertension related complications in
[302] Calvaruso V, Bronte F, Conte E, Simone F, Craxi A, Di Marco V. Modified patients with chronic liver disease: A prospective study. J Hepatol 2011;55:
spleen stiffness measurement by transient elastography is associated with 1017–1024.
presence of large oesophageal varices in patients with compensated
hepatitis C virus cirrhosis. J Viral Hepat 2013;20:867–874. [323] Poynard T, Vergniol J, Ngo Y, Foucher J, Munteanu M, Merrouche W, et al.
Staging chronic hepatitis C in seven categories using fibrosis biomarker
[303] Giannini E, Botta F, Borro P, Risso D, Romagnoli P, Fasoli A, et al. Platelet (FibroTest) and transient elastography (FibroScan(R)). J Hepatol 2014;60:
count/spleen diameter ratio: proposal and validation of a non-invasive 706–714.
parameter to predict the presence of oesophageal varices in patients with
liver cirrhosis. Gut 2003;52:1200–1205. [324] Wong GL, Chan HL, Wong CK, Leung C, Chan CY, Ho PP, et al. Liver stiffness-
based optimization of hepatocellular carcinoma risk score in patients with
[304] Giannini EG, Zaman A, Kreil A, Floreani A, Dulbecco P, Testa E, et al. Platelet chronic hepatitis B. J Hepatol 2014;60:339–345.
count/spleen diameter ratio for the noninvasive diagnosis of esophageal
varices: results of a multicenter, prospective, validation study. Am J [325] Wong VW, Chan SL, Mo F, Chan TC, Loong HH, Wong GL, et al. Clinical
Gastroenterol 2006;101:2511–2519. scoring system to predict hepatocellular carcinoma in chronic hepatitis B
carriers. J Clin Oncol 2010;28:1660–1665.
[305] Kim BK, Han KH, Park JY, Ahn SH, Kim JK, Paik YH, et al. A liver stiffness
measurement-based, noninvasive prediction model for high-risk esopha- [326] Merchante N, Rivero-Juarez A, Tellez F, Merino D, Jose Rios-Villegas M,
geal varices in B-viral liver cirrhosis. Am J Gastroenterol 2010;105: Marquez-Solero M, et al. Liver stiffness predicts clinical outcome in human
1382–1390. immunodeficiency virus/hepatitis C virus-coinfected patients with com-
pensated liver cirrhosis. Hepatology 2012;56:228–238.
[306] Park SH, Park TE, Kim YM, Kim SJ, Baik GH, Kim JB, et al. Non-invasive
model predicting clinically-significant portal hypertension in patients with [327] Macias J, Camacho A, Von Wichmann MA, Lopez-Cortes LF, Ortega E, Tural
advanced fibrosis. J Gastroenterol Hepatol 2009;24:1289–1293. C, et al. Liver stiffness measurement versus liver biopsy to predict survival
and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected
[307] Thabut D, Imbert-Bismut F, Cazals-Hatem D, Messous D, Muntenau M, patients. Aids 2013;27:2541–2549.
Valla DC, et al. Relationship between the Fibrotest and portal hypertension
in patients with liver disease. Aliment Pharmacol Ther 2007;26:359–368. [328] Pang JX, Zimmer S, Niu S, Crotty P, Tracey J, Pradhan F, et al. Liver stiffness
by transient elastography predicts liver-related complications and mortal-
ity in patients with chronic liver disease. PLoS One 2014;9:e95776.
Journal of Hepatology 2015 vol. xxx j xxx–xxx 27
Please cite this article in press as: EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. J
Hepatol (2015), http://dx.doi.org/10.1016/j.jhep.2015.04.006
